Global Content That Supports Compliance, Labeling, and Distribution
Designed for medical device teams navigating labeling complexity, regulatory compliance, and global distribution.
Why Medical Device Content Requires Consistency Across Markets
Medical device organizations face increasing regulatory oversight, expanding global markets, and rising volumes of content tied to product launches, labeling updates, and post-market obligations.
When multilingual content is not aligned, the impact goes beyond delays. Labeling inconsistencies can create compliance risk, disrupt production timelines, and affect market access.
Where Welo Life Sciences Fits
Welo Life Sciences supports medical device and IVD teams with multilingual workflows designed for regulated environments, helping organizations maintain accuracy, traceability, and control across global markets.
Labeling, including IFUs, across markets
Regulatory documentation under MDR and IVDR
Frequent updates driven by post-market findings
Growing expectations around consistency and traceability
How We Support Your Teams
Instructions for Use & Labeling
Multilingual content aligned with device labeling requirements and production constraints.
Support includes:
- IFU translation across global markets, including combined-language formats and eIFU content under Regulation (EU) 2021/2226
- Labeling and packaging content aligned with regulatory requirements and physical production constraints
- Version control supporting QMS and audit expectations
Regulatory Documentation
Documentation supporting submissions and ongoing compliance.
Support includes:
- Technical files and regulatory submissions
- Documentation aligned with MDR and IVDR frameworks
- Consistency across markets and regulatory updates
Quality & Training Content
Internal and external documentation supporting product use and compliance.
Support includes:
- Quality management system documentation, including SOPs, work instructions, and records supporting ISO 13485 compliance
- Global training materials and product education content
- HCP and end-user training content, including product education and safe-use materials
Post-Market and Vigilance Content
Multilingual support for ongoing post-market obligations.
Support includes:
- Field safety corrective action (FSCA) notices and field safety notices (FSN)
- Post-market surveillance reporting and trend documentation
- Rapid turnaround for safety-related content updates
OPAL Enable for Medical Devices
AI-powered workflows built for regulated device content
In medical devices, every word carries weight. Labeling, IFUs, regulatory documentation, and global content must remain accurate, traceable, and compliant.
OPAL Enable supports device teams with AI-enabled workflows configured for labeling and regulatory environments, combining automation with expert human oversight to scale content without compromising precision.
Built within ISO-certified quality and security frameworks, workflows are aligned to content risk. Lower-risk content moves through AI-enabled processes, while regulated materials receive expert review to ensure consistency and compliance at scale.
Why Medical Device Teams Trust Welo Life Sciences
Built for Regulatory Environments
Our workflows support medical device documentation across development, submission, and post-market phases.
AI with Governance
AI-enabled workflows increase speed while maintaining the structured quality controls required for regulated content.
Traceability and Control
Version management and terminology consistency support audit readiness and regulatory confidence.
Global Scale
Multilingual delivery supports global product distribution without increasing operational complexity.
Quality Standards
ISO 9001, ISO 13485, ISO 17100, ISO 18587, ISO/IEC 27001, ISO/IEC 27701
Support Your Device Content Strategy with Confidence
From device labeling to regulatory documentation and post-market updates, multilingual content must remain consistent, accurate, and compliant.
Welo Life Sciences helps medical device and IVD teams manage language without introducing additional risk.